May 28, 2024

IAG Invests in XTRA alongside IVC Partners: The Future of AI-Driven Healthcare



The startup led by the Raiola brothers and supported by IAG and Italians in VC Partners is revolutionizing healthcare access with an AI platform for musculoskeletal services. With innovative solutions and a growing market, it aims to transform the sector by providing timely and targeted care to millions of people worldwide.

In the increasingly interconnected landscape of the digital world, immediate access to healthcare has become an indispensable priority. However, for most of the global population, access to musculoskeletal (MSK) services remains an unattainable luxury. This is where XTRA comes into play, a pioneering startup in the digital health sector, founded by a team led by the innovative vision of Pierangelo and Michelangelo Raiola, now also supported by investors from Italian Angels for Growth (IAG) and Italians in VC Partners.

Addressing a Global Gap - Over 1.5 billion individuals worldwide lack access to the musculoskeletal (MSK) services they may need. Most of the currently available resources focus on treating chronic injuries that require long months of care, thus neglecting the urgent needs of those facing acute conditions and requiring timely and targeted care.

The Innovation of XTRA - XTRA stands out with its solution: a digital front door powered by artificial intelligence that offers immediate access to healthcare services and self-management solutions for everyone. XTRA's screening platform enables the rapid identification of patients with acute musculoskeletal (MSK) conditions, directing them to the most appropriate care pathway. Additionally, XTRA provides a self-triage navigator for the low-pain market, an AI-based support system that offers personalized guidance and self-triage for MSK conditions.

A Growing Market and Imminent Transformation - With more than 350,000 digital health applications and approximately 90,600 physical therapy clinics and rehabilitation centers in the United States alone, the market for MSK solutions is vast and continually expanding. XTRA has already demonstrated significant traction, with 20 active clients covering over 350,000 users. The startup is emerging as the leading onboarding platform for MSK services in the healthcare sector.

XTRA Vision is indeed at the forefront of developing advanced AI-based technologies for the healthcare sector, with a particular focus on musculoskeletal well-being. The startup is developing the next generation of virtual front doors to simplify, accelerate, and optimize healthcare onboarding and monitoring. It offers services such as generative symptom checking, computer vision exams, and remote patient monitoring.

Paolo Maresca and Gianfranco Giannella, Champions of IAG in this investment, state: “XTRA represents a unique opportunity in the digital health landscape. Their AI-based solution addresses a global gap in access to musculoskeletal services, offering timely and targeted care to those in need. We are proud to support founders Pierangelo and Michelangelo Raiola in this mission, and we are confident that, with our support, XTRA will continue to transform how people access and manage their health.”

Pierangelo Raiola, CEO and co-founder of XTRA, adds: “We are thrilled to welcome IAG on board our journey towards internationalization and to have an investor with aligned vision. Special thanks to Luigi Di Piazza, Gianfranco Giannella, and Paolo, who have believed strongly in us and continue to provide valuable operational insights. Thanks to them, we can accelerate our path and adopt an even more targeted approach to patient needs, a key element of our startup's success. This partnership allows us to scale our innovative solutions leveraging artificial intelligence and computer vision, where accessing a visit becomes a matter of minutes rather than weeks. We are confident in making a significant impact on global healthcare delivery. Together, we are paving the way for a future where quality care is easily accessible to all, creating a win-win scenario for both patients and healthcare providers.”